Self-guided behavioral app helps children with epilepsy sleep earlier
January 7, 2026
An evidence-based web-app helped children with epilepsy to fall asleep on average 16.5 minutes earlier.
An evidence-based web-app helped children with epilepsy to fall asleep on average 16.5 minutes earlier.
Two pioneering, clinically-led digital app solutions have won the Ripple Women’s Digital Health Challenge – a global innovation programme, delivered by Cogniss in partnership with the Health Innovation Network (the Network) and Amazon Web Services (AWS).
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common frontline therapies.
Abbott (NYSE: ABT)+
announced today that it received FDA clearance for its Amplatzer Piccolo delivery system for use with the Amplatzer Piccolo Occluder.
According to a US pivotal study, the device’s sensitivity has been reported at more than 76% on all specimens.
The Anavi system treats polycystic ovary syndrome by delivering targeted radiofrequency energy to ablate ovarian tissue to re-initiate ovulatory cycles.
TAMPERE, Finland, Dec. 14, 2025 /PRNewswire/ — Bioretec Oy (“Bioretec” or the “Company”), a pioneer in biodegradable orthopedic implants, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its magnesium alloy technology-based, biodegradable RemeOs™ DrillPin.
A new, soft, all-in-one, wearable system has been designed for continuous wireless monitoring of neonatal health in low-resource settings.
The assay is currently available in nations that recognise the CE Mark.
A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in breast cancer treatment, making immunotherapy effective against the most common tumor type, estrogen receptor-positive or luminal breast cancer.